Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology
Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology
Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects
BRG1 and BRM function antagonistically with c-MYC in adult
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co
Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac
PDF) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and
Soluble epoxide hydrolase inhibition and gene deletion are
Therapeutic and Prognostic Significance of Arachidonic Acid in
Soluble epoxide hydrolase inhibition and gene deletion are
Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent
Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects
Selective inhibition of class I but not class IIb histone
Optimization of Amide-Based Inhibitors of Soluble Epoxide
Soluble epoxide hydrolase inhibition and gene deletion are
Optimized Inhibitors of Soluble Epoxide Hydrolase Improve in Vitro
TGF-β1 induces cardiac hypertrophic responses via PKC-dependent